Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

559 ARTÍCULOS , VIENDO DEL 91 AL 105

Beyond "Psychotropic": Repurposing Psychiatric Drugs for COVID-19, Alzheimer's Disease, and Cancer

Lenze EJ, Reiersen AM, Zorumski CF, Santosh PJ.

J Clin Psychiatry. 2023 Mar 20;84(3):22r14494. doi: 10.4088/JCP.22r14494.

Improper Application of a Rivastigmine Patch to the Back of the Neck Induced Toxic Symptoms

Matsuzono K, Mita Y, Imai G, Fujimoto S.

Intern Med. 2023 Nov 1;62(21):3247-3250. doi: 10.2169/internalmedicine.1236-22. Epub 2023 Mar 22.

Brain targeting based nanocarriers loaded with resveratrol in Alzheimer's disease: A review

Jalili C, Kiani A, Gholami M, Bahrehmand F, Fakhri S, Kakehbaraei S, Kakebaraei S.

IET Nanobiotechnol. 2023 May;17(3):154-170. doi: 10.1049/nbt2.12127. Epub 2023 Mar 22.

A systematic review of specialty dementia care units in long-term care settings

Orth J, Flowers D, Betz G, Cagle JG.

Int J Geriatr Psychiatry. 2023 Apr;38(4):e5907. doi: 10.1002/gps.5907.

The Role of the Transcription Factor Nrf2 in Alzheimer's Disease: Therapeutic Opportunities

De Plano LM, Calabrese G, Rizzo MG, Oddo S, Caccamo A.

Biomolecules. 2023 Mar 17;13(3):549. doi: 10.3390/biom13030549.

From the gut to the blood-brain barrier: Novel approaches for the treatment and targeted delivery of therapeutics in Alzheimer's disease

Nicolazzo JA, Abasszade JH.

Adv Drug Deliv Rev. 2023 May;196:114818. doi: 10.1016/j.addr.2023.114818. Epub 2023 Mar 31.

Nature's toolbox against tau aggregation: An updated review of current research

Khan S, Hassan MI, Shahid M, Islam A.

Ageing Res Rev. 2023 Jun;87:101924. doi: 10.1016/j.arr.2023.101924. Epub 2023 Mar 31.

Plants of the Genus Mahonia as a Potential Traditional Chinese Medicine for the Prevention and Treatment of Alzheimer's Disease

Yang S, Shao H, Chen X, Liu Q, Huang S, Huang Y.

Curr Top Med Chem. 2023;23(13):1214-1220. doi: 10.2174/1568026623666230330105251.

[Visual analysis of research on traditional Chinese medicine treatment of Alzheimer's disease in recent ten years]

Li X, Xiao KW, Chen YQ, Huang K, Xue XC, Yang CJ, He WB, Qin YL.

Zhongguo Zhong Yao Za Zhi. 2023 Mar;48(6):1673-1681. doi: 10.19540/j.cnki.cjcmm.20221206.501.

Thiadiazole - A promising structure in design and development of anti-Alzheimer agents

Hatami M, Basri Z, Sakhvidi BK, Mortazavi M.

Int Immunopharmacol. 2023 May;118:110027. doi: 10.1016/j.intimp.2023.110027. Epub 2023 Apr 1.

The dual and emerging role of physical exercise-induced TFEB activation in the protection against Alzheimer's disease

Morais GP, de Sousa Neto IV, Marafon BB, Ropelle ER, Cintra DE, Pauli JR, Silva ASRD.

J Cell Physiol. 2023 May;238(5):954-965. doi: 10.1002/jcp.31005. Epub 2023 Apr 3.

Repurposing drugs against Alzheimer's disease: can the anti-multiple sclerosis drug fingolimod (FTY720) effectively tackle inflammation processes in AD?

Leßmann V, Kartalou GI, Endres T, Pawlitzki M, Gottmann K.

J Neural Transm (Vienna). 2023 Aug;130(8):1003-1012. doi: 10.1007/s00702-023-02618-5. Epub 2023 Apr 4.

Moving beyond amyloid and tau to capture the biological heterogeneity of Alzheimer's disease

Young-Pearse TL, Lee H, Hsieh YC, Chou V, Selkoe DJ.

Trends Neurosci. 2023 Jun;46(6):426-444. doi: 10.1016/j.tins.2023.03.005. Epub 2023 Apr 3.

Geroprotective interventions in the 3xTg mouse model of Alzheimer's disease

Sonsalla MM, Lamming DW.

Geroscience. 2023 Jun;45(3):1343-1381. doi: 10.1007/s11357-023-00782-w. Epub 2023 Apr 6.

Docosahexaenoic acid inhibits ischemic stroke to reduce vascular dementia and Alzheimer's disease

Yamagata K.

Prostaglandins Other Lipid Mediat. 2023 Aug;167:106733. doi: 10.1016/j.prostaglandins.2023.106733. Epub 2023 Apr 5.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias